United States
Seer is creating a seizure forecasting system, in collaboration with US-based Mayo Clinic and the UK-based King’s College London. The US$3 million (AU$4.2 million) grant was awarded by the Epilepsy Foundation of America for the Seizure Gauge challenge. In the Herald Sun article, Seer Co-Founder Dean Freestone states that seizure forecasting could be solved in…
Author Archives: seermedical
Seer team members, Pip Karoly, Dean Freestone and Mark Cook have had their collaborative research with the Czech Academy of Sciences (Czech Republic) published in Nature Neuroscience. Their research explores ‘critical slowing’ prior to a seizure. Critical slowing is a phenomenon that occurs as a system approaches a “critical point”. In the brain, the critical point could represent…
Seer team members, Pip Karoly, Dean Freestone and Mark Cook have had their research published in Lancet Neurology. Epilepsy has long been suspected to be governed by cyclic rhythms, with seizure rates rising and falling periodically over weeks, months, or even years. The very long scales of seizure patterns seem to defy natural explanation and…
Last week Seer officially launched a new office space, a new brand, and a new phase in the life of Seer! Thanks to everyone who came to celebrate with us – here are some photos from the night.
Hear Seer’s Lead App Developer, Pip Karoly and Director Mark Cook talk about the new Minder epilepsy monitoring device, seizure cycles and seizure forecasting on Triple R’s Einstein A Go-go Listen here.
Seer is one of only 84 finalists in the 2018 Telstra Business Awards. The prestigious program recognises the best in business across four categories: Emerging and Energised, Small and Succeeding, Medium and Making Waves, and Social Change Maker. Seer, one of over 10,000 entries in this years awards, was evaluated across a broad range of…
Seer Medical’s Mark Cook, in conjunction with The Bionics Institute, St Vincent’s Melbourne and the University of Melbourne has launched a new Australian venture to develop a breakthrough monitoring device to improve management of epilepsy and seizure-related conditions – Minder ™. The successful venture with an initial A$3.65 million investment from Cochlear Ltd and other…
Dean and Rory presented at the Novartis Digital Health Summit in Sydney on the 3rd of May. Dean talked about how our ambulatory EEG-ECG service applies digital technologies to transfer neurological, cardiac and sleep monitoring from the hospital to the home, and streamline the diagnostic process for clinicians. Rory presented a series of case studies…
Dean went to the AusMedTech meeting in Adelaide this month to participate in two panels. In the first session, Dean represented Australia’s National Digital Health – ANDHealth – Incentive and spoke about Seer Medical’s experience in the program. In the second session, he spoke about the convergence of technology in healthcare alongside representatives from Uni…
Seer Medical team are on the news talking about a trial for a brain implant to stop seizures. Watch the video here. The first person enrolled in the trial is based in Melbourne and has been using SeerGP to monitor her seizure activity.